Mesoblast (MESO) Divestments (2016 - 2023)
Mesoblast (MESO) posted quarterly Divestments of -$40000.0 for Q1 2023, down 471.43% year-on-year from $10769.2 in Q1 2022, and down 17.65% on a QoQ basis from -$34000.0 in Q4 2022.
Mesoblast (MESO) Divestments (2016 - 2023) Analysis & Trends
Mesoblast (MESO) has reported Divestments for 8 consecutive years, with -$40000.0 the latest figure, recorded in Q1 2023.
- Quarterly Divestments fell 471.43% year-over-year to -$40000.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was -$274000.0 (up 17.72% YoY) and the FY2022 annual result came in at -$157000.0, up 90.47% from the prior year.
- Divestments declined to -$40000.0 in Q1 2023 per MESO's latest filing, from -$34000.0 in the prior quarter.
- Over the last five years, Divestments for MESO reached as high as -$4000.0 in Q4 2021 and fell as low as -$936000.0 in Q1 2021.
- A 5-year average of -$252588.2 and a median of -$99000.0 in 2021 frame the typical range for Divestments.
- Annual changes were most pronounced in 2020 — Divestments sank 927.27% — and 2022, when it jumped 99.25%.
- Year by year, Divestments stood at -$459000.0 in 2019, then grew by 11.33% to -$407000.0 in 2020, then surged by 99.02% to -$4000.0 in 2021, then slumped by 750.0% to -$34000.0 in 2022, then dropped by 17.65% to -$40000.0 in 2023.
- According to Business Quant data, Divestments over the past three periods registered -$40000.0, -$34000.0, and -$153000.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -32.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mesoblast | 2.08 Bn | 1.95 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -40,000.00 |
| Dec 31, 2022 | -34,000.00 |
| Sep 30, 2022 | -153,000.00 |
| Jun 30, 2022 | -47,000.00 |
| Mar 31, 2022 | -7,000.00 |
| Dec 31, 2021 | -4,000.00 |
| Sep 30, 2021 | -99,000.00 |
| Jun 30, 2021 | -223,000.00 |
| Mar 31, 2021 | -936,000.00 |
| Dec 31, 2020 | -407,000.00 |
| Sep 30, 2020 | -81,000.00 |
| Jun 30, 2020 | -791,000.00 |
| Mar 31, 2020 | -693,000.00 |
| Dec 31, 2019 | -459,000.00 |
| Sep 30, 2019 | -153,000.00 |
| Jun 30, 2019 | -77,000.00 |
| Mar 31, 2019 | -90,000.00 |
| Dec 31, 2018 | -73,000.00 |
| Sep 30, 2018 | -39,000.00 |
| Jun 30, 2018 | -27,000.00 |